What it is
DayZero is an umbilical cord-derived stem cell preparation produced by ZEO ScientifiX, a Florida-based regenerative biologics company.
Source and manufacturing
The material is derived from human umbilical cord tissue and processed under controlled manufacturing standards by ZEO ScientifiX. ZEO holds patents related to its perinatal-tissue processing techniques and maintains an active clinical research portfolio in regenerative biologics. Donor tissue is screened in accordance with applicable standards.
How TC Regen uses it
At TC Regen, stem cell material is administered only by a licensed physician as part of an individualized treatment plan, following clinical evaluation at the Naples or Fort Myers location. It is offered for orthopedic and pain-related applications under Florida's Stem Cell Therapy Act.
Regulatory status
Umbilical cord-derived stem cell products, including DayZero, are not approved by the U.S. Food and Drug Administration. No therapeutic outcome is guaranteed. A licensed physician reviews individual risks and the written informed-consent process required under Florida law before any treatment.
Sourced from ZEO ScientifiX
MORE MATERIALS
More insights for you.
Other regenerative materials sourced and used at TC Regen.
Amniotic fluid-derived exosome material from ZEO ScientifiX, used at TC Regen under physician supervision. Not FDA-approved.
Umbilical cord-derived Wharton's Jelly Matrix from ZEO ScientifiX, used at TC Regen under physician supervision. Not FDA-approved.